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BACKGROUND—Gypsies are the groups of people 
who are not dependent on any special location.  
Because of permanent immigration, poor 
socioeconomic status and the special life style, gypsies 
might be exposed to multiple sexual partners, addiction 
and various kinds of infections, like hepatitis B virus 
(HBV), hepatitis C virus (HCV), and human 
immunodeficiency virus (HIV). The aim of this study 
was to estimate the prevalence of these infections in 
gypsies of South-West of Iran (Shahr-e-Kord).    
MATERIALS AND METHODS—This study was done 
in Sureshjan Pass near Shahr-e-Kord. Out of 250 
gypsies, 226 of them were recruited into the study. 
Laboratory tests for hepatitis B surface antigen (HBs 
Ag), hepatitis B core antibody (HBcAb), hepatitis C 
virus antibody (HCVAb), and human immunodeficiency 
virus antibody (HIVAb) were performed in the study 
population. All sera with positive results of HBsAg or 
HBcAb were tested again for these markers together 
with HBsAb, HBeAg, and HBeAb. Also sera with 
positive HIV Ab were retested with immunoblot assay. 
RESULTS—A total of 226 persons (103 males, 123 
females) with a mean age of 20.7 years (range: 9 
months to 78 years) were recruited. Thirty-five subjects 
(18, or 15.5 % male) had positive HBsAg. Fifty-four 
persons (23.9%) had positive HBcAb. Seven (4, or 3.1% 
male), had positive HCVAb and 4 persons (2, or 1.8% 
male) were HIV positive. 
CONCLUSION—Gypsies in Iran should be considered 
a high risk group for HBV, HCV and HIV infections. 
Vaccination against HBV should be considered for all 
noninfected subjects, and health promotional activity 
should be planned in order to prevent further spread of 
these blood born infections among them. 
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INTRODUCTION 
 
Viral hepatitis B, C, and HIV infection have been 
common diseases during recent decades. Co-
infection between these three different diseases 
takes place via similar routes of transmission, and 
population affected, are intravenous drug users 
(IVDU), hemophilia, dialysis patients, and health care 
workers.1  
Gypsies are groups of people who do not take up 
permanent residence in any area. Their communities 
are characterized by pervasive social health 
problems, widespread poverty, and limited 
educational opportunities. Because of permanent 
immigration and different life style, they might be 
exposed to multiple sexual partners, addiction and 
various kinds of infections. There has been limited 
studies dealing with their health status, across the world.  
Some studies in Spain have shown that HBV 
infection rate is as high as 29% among Spanish 
gypsy population.2 Similarly, a few studies in Spain 
have shown that the prevalence of HCV and HIV 
infection are higher in gypsies than in the general 
population.3, 4  
In previous studies it had been estimated that 
HBsAg carrier rate was about 3% in Iran.5  
However, universal neonatal vaccination against 
HBV, started in Iran in 1993 led to decrement of 
HBV prevalence among Iranian children.6 
According to the recent Iranian national health 
survey7 the prevalence of HBV infection is 1.7% in 
the country. Also, world prevalence of HCV 
infection is 1%. Earlier studies in Iran put HCV 
prevalence rate at about 0.3 %.5However, it seems 
that its prevalence is increasing in the country; and 
in a recent study, 0.46% of Iranian blood donors 
were HCV positive.8 Additionally, the prevalence of 
HIV positivity in Iran is about 0.0086 %, according 
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to the recent Iranian national health survey.7 
Epidemiologic studies of HBV, HCV, and HIV 
infections among gypsy population are very 
important, as they can become a potential source of 
communicable diseases. The aim of this study was 
to determine the prevalence of HBV, HCV, and HIV 
infections in Iranian gypsy population. 
 
 
MATERIALS AND METHODS  
 
This study was done in Soureshjan Pass, located 
at a distance of 3 kilometers from Shahr-e-Kord, 
(South-West of Iran). Having secured the prior 
consent of 226 out of the of total 250 gypsies, the 
age, gender history of multiple sexual partnership, 
intravenous drug use, blood transfusion, tattooing, 
and phlebotomy of  these subjects were recorded. 
Then, 10 mL of venous blood was taken from each 
person. Blood samples were centrifuged and 
underwent tests for HBsAg, HBcAb, HCVAb, and 
HIVAb. The kits used were based on third 
generation of enzyme immunoassay for HBV 
markers and HIVAb. Second generation enzyme 
immunoassay was used for HCV Ab testing. All 
positive sera for HBsAg or HBcAb were tested 
again for these markers and also for HBeAg, 
HBeAb, and HBsAb.  Also, sera with positive HIV Ab 
underwent testing with confirmatory immunoblot 
assay. For all kits used, quality control was done 
simultaneously with measurement of samples. 
Negative and positive control numbers and the mean 
were in acceptable range.  
The prevalence of HBV, HCV, and HIV 
infections in gypsies was calculated. Then, these 
values were compared with the estimated prevalence 
of HBV, HCV, and HIV infections in the normal 
population of Iran (1.7 % for HBV, 0.46 % for HCV, 
and 0.0086 % for HIV infection).7,8  
Statistical analysis was performed using the 
SPSS, version 10.1, software package (SPSS, Inc., 
Chicago, IL). Statistical analysis was also performed 
using χ2 for categorical variables. P values less than 
0.05 were considered statistically significant. 
 
 
RESULTS 
 
Among 226 participanting (out of 250) gypsies, 
there were 103 males and 123 females, with a mean 
age of 20.7 years (range: 9 months to 78 years). 
HBsAg was positive in 35 (15.5 %) subjects (18 
men, 17 women) and was about ten times more 
frequent than in the general population (RR: 10.59; 
p < 0.001). Seven (20 %) persons out of 35 HBsAg 
positive patients were HBeAg positive. Also, 41 
persons (18.1% of the study population) had 
positive HBcAb. Interestingly, 13 persons had 
positive HBsAg but negative HBcAb. Among 226 
gypsies, 7 (3.1%) persons (4 males, 3 females) had 
positive HCVAb. This prevalence was nearly ten 
times more frequent than that in the general 
population (RR: 10.06; p < 0.001). Ten persons had 
positive HIVAb with enzyme immunoassay. In 4 
(1.8 %) of them (2 males, 2 females) positive HIV 
Ab was confirmed with immunoblot assay. Thus, 
the prevalence of HIV infection among gypsies was 
210 times more frequent than that in the general 
population (RR: 210; p < 0.001). Coinfection for 
HBsAg-HCVAb (n = 2) was found in 0.9 % of the 
subjects. Triple infection (positive HBsAg, HCVAb, 
and HIV Ab) was found in one person.  
 
Risk factors 
When asked about the risk factors concerning the 
viral infections, none of the study subjects reported 
the history of intravenous drug use or multiple 
sexual partnership. Also, none of the HCV infected 
patients reported the history of blood transfusion, 
while all the seven HCV infected patients had a 
history of tattooing, and 6 (85.7 %) of them had a 
history of phlebotomy.   
 
 
DISCUSSION 
 
This is the first study to show the prevalence rate 
of HBV, HCV, and HIV infection among Iranian 
gypsies which is clearly more frequent than that in 
the general population. For example, in the recent 
Iranian national health survey, only 4 of the 46,631 
subjects examined for HIV were found to be 
positive7; however, we found 4 out of 226 subjects  
to be HIV positive. This is in accordance with the 
results of some of the earlier studies performed in 
European gypsies. For example, in Spanish studies 
HBV infection was found in 29% of the gypsies,2 
and also HCV infection in 54%3 of imprisoned 
gypsies.  
The very low level of socioeconomic status of 
this population, together with profound health 
problems renders them to acquire transmissible 
viruses such as HBV, HCV, and HIV infection. In 
our survey, none of the study subjects reported the 
history of intravenous drug use or having multiple 
sexual partners; and their response to questions was 
unreliable. However, tattooing and phlebotomy are 
very common practices among our gypsies.  
In a study of Iranian HCV infected patients, 
history of blood transfusion, illegal drug use, and 
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extramarital sexual activities were the major risk 
factors for HCV infection in Iran.9 The above issues 
are also the main risk factors for HIV infection.10 
The prevalence rate of HCV infection in Iranian 
population is about 0.46 %,8 which is lower than the 
near 1.5% prevalence in the United States.11,12 This 
may be due to the religious beliefs and the laws 
practiced in Iran.9 However, Iranian gypsies live in 
isolated communities having low level 
socioeconomic status and profound health problems. 
The very high rate of HBV, HCV, and HIV 
infection among the gypsies suggest that they might 
be exposed to the major risk factors of these 
infections. Other routes of viral transmission (e.g., 
vertical transmission, phlebotomy) and unidentifiable 
factors may also be the cause of the infections.  
The alarming high rate of HBV, HCV, and HIV 
infections among the gypsies, not only puts these 
infected patients at greater risk for complications 
such as end stage liver disease and AIDS, but it also 
makes them a potential source of transmission of these 
viruses to the general population. The governmental 
law enforcement should be focused on reducing the 
rate of infections among gypsies. In addition to the 
universal neonatal HBV vaccination, HBV vaccination 
of all uninfected gypsies is important. In Taiwan, 
universal neonatal HBV vaccination led to the 
reduction of HBV carrier rate and childhood 
hepatocellular carcinoma.13 The benefit of universal 
neonatal HBV vaccination has also been observed in 
Iran.6 Educative efforts to reduce HCV, and HIV 
infection (e.g., avoidance of needle sharing among 
intravenous drug users, and protected sexual activities) 
should also be implemented in the gypsy population. 
Interestingly, we found an unusual serologic 
pattern of HBV infection in some study patients. 
Thirteen of 35 HBsAg positive patients had 
negative HBcAb. Although, this may be due to 
laboratory error, but it may also represent a 
subgroup of HBV carriers. Certainly, further 
studies are needed to clarify virologic, 
biochemical, and liver histologic characteristics 
of these patients. In conclusion, the high rate of 
HBV, HCV, and HIV infections among gypsies 
is an important health concern in our country. 
Future studies should be directed to better 
identifying of the major routes of transmission of 
the infections among  the  population  and finding the 
best ways to reducing transmission of the diseases. 
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